Abteilung für Klinische Chemie und Klinische Biochemie, Ludwig-Maximilians-Universität, Nussbaumstrasse 20, D-80336 München, Germany.
Biol Chem. 2011 Nov;392(11):1011-20. doi: 10.1515/BC.2011.164.
WNT/Frizzled receptor (FZD) signaling pathways are pivotal for physiological and pathophysiological processes. In humans, the complexity of WNT/FZD signaling is based on 19 WNTs, 10 FZDs and at least two (co)receptors (LRP5/6) mediating supposably four different signaling cascades. The detailed investigation of the specific function of the different initiating components is primarily hampered by the lack of most WNT proteins in a purified form. Therefore, we constructed and examined a chimeric protein of WNT3a and FZD4 as a suitable approach to overcome this obstacle for future studies of the specificity of other WNT/FZD combinations. Furthermore, we produced four different reporter HEK 293 cell lines to quantify the induced activation of the proposed signaling cascades, the β-catenin-, the NFAT-, the AP-1- and the CRE-regulated pathways. The chimera WNT3aFZD4 efficiently induced β-catenin-mediated luciferase activity. This activity was increased 40-fold compared with basal when LRP6 was stably cotransfected, proving that the chimera WNT3aFZD4 can also interact efficiently with LRP6. Our results demonstrate that the approach of using reporter gene cell lines in combination with WNT/FZD chimeras is efficient to study the β-catenin-mediated pathway and should also allow clarifying the specificity of WNT/FZD combinations in the activation of the other pathways.
WNT/Frizzled 受体(FZD)信号通路对于生理和病理生理过程至关重要。在人类中,WNT/FZD 信号的复杂性基于 19 种 WNTs、10 种 FZD 和至少两种(共)受体(LRP5/6),介导假设的四种不同的信号级联。不同起始成分的特定功能的详细研究主要受到缺乏大多数 WNT 蛋白的纯化形式的阻碍。因此,我们构建并检查了 WNT3a 和 FZD4 的嵌合蛋白,作为克服未来研究其他 WNT/FZD 组合特异性的这一障碍的合适方法。此外,我们产生了四种不同的报告基因 HEK 293 细胞系,以定量测定所提议的信号级联的诱导激活,β-连环蛋白、NFAT、AP-1 和 CRE 调节途径。嵌合蛋白 WNT3aFZD4 有效地诱导β-连环蛋白介导的荧光素酶活性。与稳定共转染时的基础相比,该活性增加了 40 倍,证明嵌合蛋白 WNT3aFZD4 还可以与 LRP6 有效地相互作用。我们的结果表明,使用报告基因细胞系与 WNT/FZD 嵌合体相结合的方法可有效地研究β-连环蛋白介导的途径,并且还应该澄清 WNT/FZD 组合在其他途径的激活中的特异性。